Nandakumar Packiriswamy

2PUBLICATIONS
12CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 22, 2026
Phase I Study of Oncolytic Virus VV1 as Monotherapy or in Combination with Avelumab in Patients with Relapsed Refractory Solid Tumors.

|Apr 25, 2020
Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma.

Nandakumar Packiriswamy, Deepak Upreti, Yumei Zhou

Pageof 1

Frequent Collaborators

1 joint publications

Jaime R Merchan

1 joint publications

Manish R Patel

1 joint publications

Timothy P Cripe

1 joint publications

Matthew O Old